BASF Adjusts 2025 Outlook as Margin Pressures Weigh on Q2 Earnings

BASF reported second quarter 2025 sales of €15.8 billion, slightly below the prior-year period due to negative currency effects and lower prices, especially in the Chemicals segment. EBITDA before special items declined to €1.8 billion, down from €2 billion a year ago, reflecting margin pressure in base chemicals despite earnings growth in Agricultural Solutions, Surface Technologies and Nutrition & Care.

Net income dropped to €79 million from €430 million in Q2 2024, impacted by lower earnings from shareholdings and structural cost-saving charges. Free cash flow rose €62 million year over year to €533 million, as major investments in China tapered off.